High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Human Molecular Genetics

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/DDI361PMID 16195395
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region.

  2005influential reference
• novoSNP, a novel computational tool for sequence variation discovery.

  2005cited by this paper
• SNPbox: a modular software package for large-scale primer design

  2005cited by this paper
• A common inversion under selection in Europeans

  2005cited by this paper
• Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration

  2005cited by this paper
• Tau haplotypes regulate transcription and are associated with Parkinson's disease

  2004cited by this paper
• The role of tau (MAPT) in frontotemporal dementia and related tauopathies

  2004cited by this paper
• Novel haplotypes in 17q21 are associated with progressive supranuclear palsy

  2004cited by this paper
• The structure of the tau haplotype in controls and in progressive supranuclear palsy.

  2004cited by this paper
• Linkage disequilibrium and association of MAPT H1 in Parkinson disease.

  2004cited by this paper
• Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype

  2004cited by this paper
• Transcription factor CP2 is involved in activating mBMP4 in mouse mesenchymal stem cells.

  2004cited by this paper
• Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank

  2003cited by this paper
• The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population.

  2002cited by this paper
• Score tests for association between traits and haplotypes when linkage phase is ambiguous.

  2002cited by this paper
• Apolipoprotein E and Intellectual Achievement

  2002influential reference
• Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy

  2001cited by this paper
• Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene

  2001cited by this paper
• Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study.

  2001influential reference
• Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

  2001cited by this paper
• An extended 5′-tau susceptibility haplotype in progressive supranuclear palsy

  2000cited by this paper
• Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy

  2000cited by this paper
• Molecular Cloning and Characterization of the Human Glycogen Synthase Kinase-3β Promoter

  1999cited by this paper
• Purification and Characterization of the Serum Amyloid A3 Enhancer Factor*

  1999cited by this paper
• Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter.

  1999cited by this paper
• Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

  1999cited by this paper
• The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases

  1999cited by this paper
• Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease

  1998cited by this paper
• Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection.

  1998cited by this paper
• Tau is a candidate gene for chromosome 17 frontotemporal dementia

  1998cited by this paper
• Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990

  1997cited by this paper
• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• A τ Promoter Region Without Neuronal Specificity

  1996cited by this paper
• A tau promoter region without neuronal specificity.

  1996cited by this paper
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

  1995influential reference
• Microtubule organization and dynamics dependent on microtubule-associated proteins.

  1994cited by this paper
• Handbook of Human Genetic Linkage

  1994cited by this paper
• Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

  1989cited by this paper

• Chr:17q21.31 locus risk haplotype H1 susceptibility to ferroptosis is mediated by endolysosomal pathway

  2025cites this paper
• The potential of mulberry (Morus alba L.) leaf extract against pro-aggregant tau-mediated inflammation and mitochondrial dysfunction.

  2025cites this paper
• MAPT Subhaplotypes in Different Progressive Supranuclear Palsy Phenotypes

  2025cites this paper
• Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic component

  2025cites this paper
• Cerebral perfusion alterations in healthy young adults due to two genetic risk factors of Alzheimer’s disease: APOE and MAPT

  2025cites this paper
• Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and MAPT Sub-haplotypes

  2024cites this paper
• Endoplasmic reticulum stress and its role in various neurodegenerative diseases.

  2023cites this paper
• Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue

  2023cites this paper
• Rescue of the increased susceptibility to Mild Chronic Oxidative Stress of iNeurons carrying the MAPT Chromosome 17q21.3 H1/H1 risk allele by FDA-approved compounds

  2022influential citation
• Genetics of progressive supranuclear palsy in a Chinese population.

  2022cites this paper
• Investigational therapeutics for the treatment of progressive supranuclear palsy

  2022cites this paper
• Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

  2022cites this paper
• Atypical parkinsonism, parkinsonism-plus syndromes and secondary parkinsonian disorders

  2021cites this paper
• Latent trait modeling of tau neuropathology in progressive supranuclear palsy

  2021cites this paper
• Tau and MAPT genetics in tauopathies and synucleinopathies.

  2021cites this paper
• MAPT Gene

  2020cites this paper
• Genetics of Progressive Supranuclear Palsy: A Review

  2020cites this paper
• Association of MAPT subhaplotypes with clinical and demographic features in Parkinson’s disease

  2020cites this paper
• 17q21.31 Sub-Haplotypes Underlying H1-Associated Risk for Parkinson's Disease and Progressive Supranuclear Palsy Converge on Altered Glial Regulation

  2020cites this paper
• Genetics of Chronic Traumatic Encephalopathy

  2020cites this paper
• Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects

  2020cites this paper
• MAPT rs242557 variant is associated with hippocampus tau uptake on 18F-AV-1451 PET in non-demented elders

  2019cites this paper
• Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.

  2019cites this paper
• Clinical variability and onset age modifiers in an extended Belgian GRN founder family.

  2018cites this paper
• Neglected Functions of TFCP2/TFCP2L1/UBP1 Transcription Factors May Offer Valuable Insights into Their Mechanisms of Action

  2018cites this paper
• Atypical parkinsonian syndromes: a general neurologist's perspective

  2018cites this paper
• Association of microtubule-associated protein tau gene polymorphisms with the risk of sporadic Alzheimer's disease: a meta-analysis

  2018cites this paper
• Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review

  2018cites this paper
• Meta-analysis of the association between variants in MAPT and neurodegenerative diseases

  2017cites this paper
• Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau

  2017cites this paper
• Genome-wide association study identifies MAPT locus influencing human plasma tau levels

  2017cites this paper
• A clinicopathological approach to the diagnosis of dementia

  2017cites this paper
• Tau mis-splicing in the pathogenesis of neurodegenerative disorders

  2016cites this paper
• Tremor in progressive supranuclear palsy.

  2016cites this paper
• Influência dos haplótipos, expressão total e splicing alternativo do gene MAPT no parkinsonismo em idosos

  2016cites this paper
• Tau and tauopathies.

  2016cites this paper
• Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci

  2016cites this paper
• Corticobasal degeneration and progressive supranuclear palsy

  2016cites this paper
• Molecular genetics of early‐onset Alzheimer's disease revisited

  2016cites this paper
• MAPT haplotype diversity in multiple system atrophy.

  2016cites this paper
• The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease

  2016cites this paper
• Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE ε4 Carriers in a Population of Southern India

  2016cites this paper
• Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property.

  2016cites this paper
• The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults

  2016cites this paper
• Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.

  2016cites this paper
• Perk Genetic Variation and Function in Progressive Supranuclear Palsy

  2015cites this paper
• Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank

  2015cites this paper
• Studying tauopathies in Drosophila: A fruitful model.

  2015cites this paper
• Comment: Progressive supranuclear palsy and environmental toxins

  2015cites this paper
• Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals

  2015cites this paper
• Genetics of Progressive Supranuclear Palsy

  2015cites this paper
• Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

  2015cites this paper
• Regulation of human MAPT gene expression

  2015cites this paper
• A geographical cluster of progressive supranuclear palsy in northern France

  2015influential citation
• Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers

  2014influential citation
• Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration

  2014cites this paper
• Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration.

  2014cites this paper
• Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias

  2014influential citation
• Targets and Small Molecules Against Tauopathies. Part 1: From Genes to Soluble, Aggregation-Prone Tau Proteins

  2014cites this paper
• Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels

  2014cites this paper
• An Epigenetic Signature in Peripheral Blood Associated with the Haplotype on 17q21.31, a Risk Factor for Neurodegenerative Tauopathy

  2014cites this paper
• An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease.

  2013cites this paper
• Co-enzyme Q10 to treat neurological disorders: basic mechanisms, clinical outcomes, and future research direction.

  2013cites this paper
• Síndrome de Steele Richardson y Olzewski (parálisis supranuclear progresiva). Reporte de un caso clínico y revisión bibliográfica

  2013cites this paper
• The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer’s disease

  2013cites this paper
• Mouse models for the investigation of MAPT and its role in neurodegenerative disease

  2013cites this paper
• Variation in tau isoform expression in different brain regions and disease states.

  2013cites this paper
• Fifty years of progressive supranuclear palsy

  2013cites this paper
• Tau expression varies in different brain regions and disease state

  2013cites this paper
• MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis.

  2013cites this paper
• Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy

  2013influential citation
• Cellular minigene models for the study of allelic expression of the tau gene and its role in progressive supranuclear palsy

  2013influential citation
• MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome

  2013cites this paper
• The Handbook Of Alzheimer's Disease And Other Dementias (Softcover)

  2013cites this paper
• Tau alternative splicing in familial and sporadic tauopathies.

  2012cites this paper
• The role of MAPT sequence variation in mechanisms of disease susceptibility.

  2012cites this paper
• Common inversion polymorphism at 17q21.31 affects expression of multiple genes in tissue-specific manner

  2012cites this paper
• H1-MAPT and the Risk for Familial Essential Tremor

  2012cites this paper
• The genetics and neuropathology of frontotemporal lobar degeneration

  2012cites this paper
• Tau Isoform Composition Influences Rate and Extent of Filament Formation*

  2012influential citation
• Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)

  2011cites this paper
• Identifying the genetic components underlying the pathophysiology of movement disorders

  2011influential citation
• Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy

  2011cites this paper
• Pathogenesis of the Tauopathies

  2011cites this paper
• Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.

  2011cites this paper
• MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy

  2011cites this paper
• Corticobasal degeneration: a pathologically distinct 4R tauopathy

  2011cites this paper
• Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.

  2011cites this paper
• Independent and joint effects of the MAPT and SNCA genes in Parkinson disease

  2011cites this paper
• SNCA, MAPT, and GSK3B in Parkinson disease: a gene–gene interaction study

  2011cites this paper
• Recent advances in progressive supranuclear palsy: a review.

  2011cites this paper
• Progressive supranuclear palsy and corticobasal degeneration.

  2011cites this paper
• Chapter 9 – Atypical parkinsonism, parkinsonism-plus syndromes, and secondary parkinsonian disorders

  2011cites this paper
• Tau gene promoter rs242557 and allele-specific protein binding

  2011cites this paper
• Progressive Supranuclear Palsy: expanding the clinical and genetic spectrum

  2011cites this paper
• Linkage, Association, And Haplotype Analysis: A Spectrum Of Approaches To Elucidate The Genetic Influences Of Complex Human Traits

  2011cites this paper
• Tumefactive demyelination, an uncommon form of tacrolimus neurotoxicity

  2011cites this paper
• Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse

  2010cites this paper
• Tau pathology and future therapeutics.

  2010cites this paper
• Association of the MAPT locus with Parkinson’s disease

  2010cites this paper